Spondyloarthritiden einschließlich Psoriasis-Arthritis

Spondyloarthritis - Sakroillitis - Psoriasis

spondyloarthritis - sacroillitis - psoriasis

Literatur

• 1 Ahlehoff O, Gislason G H, Charlot M, Jørgensen C H, Lindhardsen J, Olesen J B, Abildstrøm S Z, Skov L, Torp-Pedersen C, Hansen P R. Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study.  J Intern Med. 2011;  270 147-157
• 2 Braun J, van den Berg R, Baraliakos X. et al . 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis.  Ann Rheum Dis. 2011;  70 896-904
• 3 Glintborg B, Østergaard M, Dreyer L. et al . Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti-tumor necrosis factor α therapy: Results from the nationwide Danish DANBIO registry.  Arthritis Rheum. 2011;  63 382-390
• 4 Jamnitski A, Visman I M, Peters M J, Boers M, Dijkmans B A, Nurmohamed M T. Prevalence of cardiovascular diseases in psoriatic arthritis resembles that of rheumatoid arthritis.  Ann Rheum Dis. 2011;  70 875-876
• 5 Madsen K B, Jurik A G. Magnetic resonance imaging grading system for active and chronic spondylarthritis changes in the sacroiliac joint.  Arthritis Care Res. 2010;  62 11-18
• 6 Mease P, Genovese M C, Gladstein G. et al . Abatacept in the treatment of patients with psoriatic arthritis: Results of a double-blind, randomized, placebo-controlled phase 2 trial.  Arthritis Rheum. 2011;  63 939-948
• 7 Mease P J. Psoriatic arthritis: update on pathophysiology, assessment and management.  Ann Rheum Dis. 2011;  70 (Suppl 1) i77-84
• 8 Rudwaleit M, Jurik A G, Hermann K G, Landewé R, van der Heijde D, Baraliakos X, Marzo-Ortega H, Ostergaard M, Braun J, Sieper J. Defining active sacroiliitis on Magnetic Resonance Imaging (MRI) for classification of axial spondyloarthritis – a consensual approach by the ASAS/ OMERACT MRI Group.  Ann Rheum Dis. 2009;  68 1520-1527
• 9 Rudwaleit M, van der Heijde D. et al . The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general.  Ann Rheum Dis. 2011;  70 25-31
• 10 Rudwaleit M, van der Heijde D. et al . The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.  Ann Rheum Dis. 2009;  68 777-783
• 11 Song I H, Heldmann F, Rudwaleit M, Haibel H, Weiss A, Braun J, Sieper J. Treatment of active ankylosing spondylitis with abatacept: an open-label, 24-week pilot study.  Ann Rheum Dis. 2011;  70 1108-1110
• 12 Song I H, Heldmann F, Rudwaleit M, Listing J, Appel H, Braun J, Sieper J. Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed.  Arthritis Rheum. 2010;  62 1290-1297
• 13 Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H. CASPAR Study Group . Classification criteria for psoriatic arthritis: development of new criteria from a large international study.  Arthritis Rheum. 2006;  54 2665-2673
• 14 van der Heijde D, Sieper J, Maksymowych W P, Dougados M, Burgos-Vargas R, Landewé R, Rudwaleit M, Braun J. Assessment of SpondyloArthritis international Society . 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis.  Ann Rheum Dis. 2011;  70 905-908
• 15 Weber U, Lambert R G, Østergaard M, Hodler J, Pedersen S J, Maksymowych W P. The diagnostic utility of magnetic resonance imaging in spondylarthritis.  Arthritis Rheum. 2010;  62 3048-3058